PFIZER INC.
Ownership & governance
Executives 5Directors 10Avg age 64Avg tenure 10.2y
AB
Albert Bourla
Chief Executive Officer
Age 64Since 2018-12-31Profile →
+14
Executives5
AB
Albert Bourla→
Chief Executive Officer
Age 64Since 2018-12-31
DD
David Denton
Director of Finance/CFO
Age 60Since 2022-05-01
AA
Annaliesa Anderson
Chief Tech/Sci/R&D Officer
—Since 2006-12-31
RJ
Rady Johnson
Compliance Officer
Age 65Since 2013-11-30
LF
Lidia Fonseca
Chief Tech/Sci/R&D Officer
Age 57—
Board of directors10
SJ
Suzanne Johnson→
Director/Board Member
Age 68Since 2007-08-31
SN
Shantanu Narayen→
Director/Board Member
Age 62Since 2013-09-26
AB
Albert Bourla→
Chairman
Age 64Since 2019-12-31
JS
Jim Smith→
Director/Board Member
Age 66Since 2014-06-25
JE
Joseph Echevarria→
Director/Board Member
Age 69Since 2015-06-24
RB
Ronald Blaylock→
Director/Board Member
Age 66Since 2017-02-22
DL
Dan Littman→
Director/Board Member
Age 73Since 2018-03-04
SG
Scott Gottlieb→
Director/Board Member
Age 53Since 2019-06-26
Shareholders4
| Name | Stake | Shares |
|---|---|---|
| Vanguard Capital Management LLC | 6.482 % | 369,430,012 |
| BlackRock Advisors LLC | 6.257 % | 356,638,574 |
| STATE STREET CORPORATION | 5.292 % | 301,589,865 |
| Geode Capital Management LLC | 2.343 % | 133,561,742 |
Catalog · 2026-07-09
Registry officers11
| Name | Role | Since | Shares |
|---|---|---|---|
| Albert Bourla | Chairman | 2019-12-31 | - |
| Dan Littman | Director/Board Member | 2018-03-04 | - |
| James Quincey | Director/Board Member | 2020-02-26 | - |
| Jim Smith | Director/Board Member | 2014-06-25 | - |
| Joseph Echevarria | Director/Board Member | 2015-06-24 | - |
| Ronald Blaylock | Director/Board Member | 2017-02-22 | - |
| Scott Gottlieb | Director/Board Member | 2019-06-26 | - |
| Shantanu Narayen | Director/Board Member | 2013-09-26 | - |
Registry · as of 2026-07-09
Group companies
| Name | Category |
|---|---|
| Pfizer PFE Italy Holdco SARL | — |
| Pfizer Europe Holdings SARL | Financial Conglomerates |
| Pfizer Group Luxembourg SARL | Financial Conglomerates |
| Pfizer Group Luxembourg SARL | Financial Conglomerates |
| Pfizer Ireland Pharmaceuticals ULC | Financial Conglomerates |
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus buyMean target 29.26Range 25–36Analysts 26
25Mean 29.2636
- Strong buy 2
- Buy 8
- Hold 16
- Sell 1
- Strong sell 1
Broker actions40 of 305
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| JP Morgan | Maintained | Neutral | 30 | 2026-10-09 |
| Cantor Fitzgerald | Maintained | Neutral | 28 | 2026-10-08 |
| Scotiabank | Maintained | Sector Outperform | 33 | 2026-10-06 |
| HSBC | Maintained | Hold | 30 | 2026-09-10 |
| Guggenheim | Maintained | Buy | 31 | 2026-08-07 |
| BMO Capital | Maintained | Outperform | 30 | 2026-07-13 |
| Guggenheim | Maintained | Buy | 35 | 2026-07-13 |
| B of A Securities | Maintained | Neutral | 26 | 2026-07-10 |
| JP Morgan | Maintained | Neutral | 28 | 2026-07-08 |
| Cantor Fitzgerald | Reiterated | Neutral | 27 | 2026-07-06 |
| HSBC | Downgrade | Hold | 28 | 2026-07-06 |
| RBC Capital | Upgrade | Sector Perform | 25 | 2026-06-10 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.